This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Ares Trading S.a., Zymogenetics, Inc., Mayo Foundation for Medical Education and Research. Active years: 2010-2014.
Company Filing History:
2 out of 139 
2 out of 723 
1 out of 1,802 
Years Active: 2010-2014
Title: Ivan Nestorov: Innovator in Autoimmune Disease Treatment
Introduction
Ivan Nestorov is a notable inventor based in Issaquah, WA (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases and B-cell malignancies. With a total of 2 patents, Nestorov's work is paving the way for innovative therapeutic approaches.
Latest Patents
Nestorov's latest patents include groundbreaking methods for treating autoimmune diseases using a TACI-Ig fusion molecule. This invention provides methods and compositions for the treatment of autoimmune diseases, such as rheumatoid arthritis, by administering a TACI-Ig fusion molecule to patients in need. The molecule is designed to slow, suppress, or inhibit the proliferation-inducing functions of BlyS and APRIL. Additionally, he has developed methods for treating B-cell malignancies, including non-Hodgkin's lymphoma, using the same TACI-Ig fusion molecule to suppress the proliferation-inducing functions of BlyS and APRIL.
Career Highlights
Throughout his career, Nestorov has worked with prominent companies such as Ares Trading S.a. and Zymogenetics, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.
Collaborations
Nestorov has collaborated with notable professionals in his field, including Herve Broly and Sharon J Busby. These collaborations have likely enhanced his research and development efforts.
Conclusion
Ivan Nestorov is a distinguished inventor whose work in autoimmune disease treatment and B-cell malignancies is making a significant impact in the medical field. His innovative approaches and collaborations continue to advance therapeutic options for patients.